BMJ BYGGESELSKAB 2003 ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
Loading...

Loading...

Loading...

Loading...

Loading...

Loading...

Loading...

Bankruptcy Risk 
2017
2018/6
2018
2019/6
2019
2020/6
2020
2021/6
2021
2022/6
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  2.0% 1.4% 2.2% 3.3% 20.2%  
Credit score (0-100)  71 81 67 54 5  
Credit rating  A A BBB BBB B  
Credit limit (kDKK)  0.2 19.3 0.1 0.0 0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2017
2018/6
2018
2019/6
2019
2020/6
2020
2021/6
2021
2022/6

Net sales  429 442 0 0 0  
Gross profit  337 365 317 72.5 159  
EBITDA  252 279 174 10.6 46.9  
EBIT  190 217 112 -51.3 -9.8  
Pre-tax profit (PTP)  155.4 187.6 91.8 -94.0 86.0  
Net earnings  121.2 146.4 77.9 -73.3 79.1  
Pre-tax profit without non-rec. items  155 188 91.8 -94.0 86.0  

 
See the entire income statement

Balance sheet (kDKK) 
2017
2018/6
2018
2019/6
2019
2020/6
2020
2021/6
2021
2022/6

Tangible assets total  3,696 3,634 3,572 3,510 0.0  
Shareholders equity total  1,586 1,732 1,810 1,736 1,816  
Interest-bearing liabilities  1,817 1,650 1,652 1,576 0.0  
Balance sheet total (assets)  3,921 3,937 4,020 3,782 2,132  

Net Debt  1,639 1,431 1,284 1,367 -2,103  
 
See the entire balance sheet

Volume 
2017
2018/6
2018
2019/6
2019
2020/6
2020
2021/6
2021
2022/6

Net sales  429 442 0 0 0  
Net sales growth  3.0% 3.0% -100.0% 0.0% 0.0%  
Gross profit  337 365 317 72.5 159  
Gross profit growth  -4.3% 8.2% -13.0% -77.1% 118.8%  
Employees  1 1 1 1 1  
Employee growth %  0.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  3,921 3,937 4,020 3,782 2,132  
Balance sheet change%  0.0% 0.4% 2.1% -5.9% -43.6%  
Added value  252.1 278.9 174.3 10.6 46.9  
Added value %  58.7% 63.1% 0.0% 0.0% 0.0%  
Investments  -124 -124 -124 -124 -3,567  

Net sales trend  1.0 2.0 -1.0 0.0 0.0  
EBIT trend  2.0 3.0 4.0 -1.0 -2.0  

Profitability 
2017
2018/6
2018
2019/6
2019
2020/6
2020
2021/6
2021
2022/6
EBITDA %  58.7% 63.1% 0.0% 0.0% 0.0%  
EBIT %  44.3% 49.1% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  56.4% 59.5% 35.4% -70.7% -6.2%  
Net Earnings %  28.2% 33.1% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  42.7% 47.1% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  36.2% 42.4% 0.0% 0.0% 0.0%  
ROA %  4.9% 5.5% 2.8% -1.3% 5.6%  
ROI %  5.2% 5.9% 3.0% -1.4% 6.1%  
ROE %  8.0% 8.8% 4.4% -4.1% 4.5%  

Solidity 
2017
2018/6
2018
2019/6
2019
2020/6
2020
2021/6
2021
2022/6
Equity ratio %  40.4% 44.0% 45.0% 45.9% 85.2%  
Relative indebtedness %  489.1% 436.2% 0.0% 0.0% 0.0%  
Relative net indebtedness %  447.6% 386.7% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  650.1% 513.1% 736.7% 12,910.8% -4,480.7%  
Gearing %  114.6% 95.3% 91.3% 90.8% 0.0%  
Net interest  0 0 0 0 0  
Financing costs %  1.8% 1.7% 1.2% 2.6% 10.0%  

Liquidity 
2017
2018/6
2018
2019/6
2019
2020/6
2020
2021/6
2021
2022/6
Quick Ratio  0.5 0.7 1.3 1.0 6.7  
Current Ratio  0.5 0.7 1.3 1.0 6.7  
Cash and cash equivalent  177.9 219.2 368.4 209.4 2,103.0  

Capital use efficiency 
2017
2018/6
2018
2019/6
2019
2020/6
2020
2021/6
2021
2022/6
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  52.4% 68.7% 0.0% 0.0% 0.0%  
Net working capital  -223.3 -142.3 104.8 -4.8 1,815.6  
Net working capital %  -52.0% -32.2% 0.0% 0.0% 0.0%  

Employee efficiency 
2017
2018/6
2018
2019/6
2019
2020/6
2020
2021/6
2021
2022/6
Net sales / employee  429 442 0 0 0  
Added value / employee  252 279 174 11 47  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  252 279 174 11 47  
EBIT / employee  190 217 112 -51 -10  
Net earnings / employee  121 146 78 -73 79